Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism

Archives of Toxicology

Volumn 77, Issue 5, 2003, Pages 261-266

  Ligocka, Danuta ^a,b   Lison, Dominique ^a   Haufroid, Vincent ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

2 Hydroxy N methylsuccinimide; 5 Hydroxy N methyl 2 pyrrolidone; Biological monitoring; Cytochrome P450 2E1; N Methyl 2 pyrrolidone

Indexed keywords

1 METHYL 2 PYRROLIDINONE; 2 PYRROLIDONE DERIVATIVE; 5 HYDROXY N METHYL 2 PYRROLIDONE; CYTOCHROME P450 2E1; DIETHYLDITHIOCARBAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; MICHAELIS CONSTANT; MICROSOME; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SKIN ABSORPTION; URINALYSIS; URINARY EXCRETION; URINE LEVEL; XENOBIOTIC METABOLISM;

ANIMALIA;

EID: 0038131815     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-003-0440-4     Document Type: Article

References (23)

1. Åkesson B, Jönsson BA (1997) Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab Dispos 25:267-269
2. Åkesson B, Jönsson BA (2000a) Dermal absorption study of N-methyl-2-pyrrolidone in male and female volunteers. Scientific Programme and Abstracts of the 26th International Congress on Occupational Health, Singapore, p 312
3. Åkesson B, Jönsson BA (2000b) Biological monitoring of N-methyl-2-pyrrolidone using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as the biomarker. Scand J Work Environ Health 26:213-218
4. Åkesson B, Paulsson K (1997) Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 54:236-240
5. Beaulieu HJ, Schmerber KR (1991) N-Pyrol (NMP) use in the microelectronic industry. Appl Occup Environ Hyg 6:874-880
6. Becci PJ, Knickerbocker MJ, Reagan EL, Parent RA, Burnette LW (1982) Teratogenicity study of N-methylpyrrolidone after dermal application to Sprague-Dawley rats. Fundam Appl Toxicol 2:73-76
7. Chung HC, Sung SH, Kim JS, Kim YC, Kim SG (2001) Lack of cytochrome P450 2E1 (CYP2E1) induction in the rat liver by starvation without coprophagy. Drug Metab Dispos 29:213-216
8. Frye RF, Branch RA (2002) Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects. Br J Clin Pharmacol 53:155-162
9. Haufroid V, Toubeau F, Clippe A, Buysschaert M, Gala JL, Lison D (2001) Real-time quantification of cytochrome P4502E1 mRNA in human peripheral blood lymphocytes by reverse transcription-PCR: method and practical application. Clin Chem 47:1126-1129
10. HSDB (2002) Hazardous Substances Data Bank. 1-Methyl-2-pyrrolidinone. US National Library of Medicine, Bethesda MD. Available online via NIH TOXNET http://toxnet.nlm.nih.gov/cgi-bin/sis/search/
11. Jungbauer FH, Coenraads PJ, Kardaun SH (2001) Toxic hygroscopic contact reaction to N-methyl-2-pyrrolidone. Contact Dermatitis 45:303-304
12. Kim RB, Yamazaki H, Chiba D, Oshea D, Mimura M, Guengerich FP, Ishizaki T, Shimada T, Wilkinson GR (1996) In vitro and in vivo characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther 279: 4-11
13. Lee KP, Chromey NC, Culik R, Barnes JR, Schneider PW (1987) Toxicity of N-methyl-2-pyrrolidone (NMP): teratogenic, subchronic, and two-year inhalation studies. Fundam Appl Toxicol 9:222-235
14. Leira HL, Tiltnes A, Svendsen K, Vetlesen L (1992) Irritant cutaneous reactions to N-methyl-2-pyrrolidone (NMP). Contact Dermatitis 27:148-150
15. Lieber, CS (1997) Cytochrome P-450: its physiological and pathological role. Physiol Rev 77:517-544
16. Ligocka D, Lison D, Haufroid V (2002) Quantitative determination of 5-hydroxy-N-methylpyrrolidone in urine for biological monitoring of N-methylpyrrolidone exposure. J Chromatogr B Biomed Sci Appl 778:223-230
17. Lucas D, Berthou F, Girre C, Poitrenaud F, Menez JF (1993) High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans. J Chromatogr 622:79-86
18. Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, Berthou F (1999) Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics 9:377-388
19. Mizuno D, Tanaka E, Tanno K, Misawa S (2000) Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats. Arch Toxicol 74:139-144
20. Raucy JL, Schultz ED, Kearins MC, Arora S, Johnston DE, Omdahl JL, Eckmann L, Carpenter SP (1999) CYP2E1 expression in human lymphocytes from various ethnic populations. Alcohol Clin Exp Res 23:1868-1874
21. Solomon HM, Burgess BA, Kennedy GL, Jr., Staples RE (1995) 1-Methyl-2-pyrrolidone (NMP): reproductive and developmental toxicity study by inhalation in the rat. Drug Chem Toxicol 18:271-293
22. 14C] N-methyl-2- pyrrolidinone in the rat. Drug Metab Dispos 16:243-249
23. Wells DA, Hawi AA, Digenis GA (1992) Isolation and identification of the major urinary metabolite of N-methylpyrrolidinone in the rat. Drug Metab Dispos 20:124-126